Arrowhead Pharmaceuticals, Inc. (ARWR): Price and Financial Metrics


Arrowhead Pharmaceuticals, Inc. (ARWR)

Today's Latest Price: $49.20 USD

0.14 (0.29%)

Updated Nov 22 4:00pm

Add ARWR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 327 in Biotech

See all "A" rated Strong Buy stocks

ARWR Stock Summary

  • For ARWR, its debt to operating expenses ratio is greater than that reported by just 0.39% of US equities we're observing.
  • With a year-over-year growth in debt of -100%, Arrowhead Pharmaceuticals Inc's debt growth rate surpasses only 0% of about US stocks.
  • Revenue growth over the past 12 months for Arrowhead Pharmaceuticals Inc comes in at 905.49%, a number that bests 99.14% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Arrowhead Pharmaceuticals Inc, a group of peers worth examining would be CRBP, XNCR, AFMD, VYGR, and CRSP.
  • Visit ARWR's SEC page to see the company's official filings. To visit the company's web site, go to arrowheadpharma.com.
ARWR Daily Price Range
ARWR 52-Week Price Range

ARWR Stock Price Chart More Charts


ARWR Price/Volume Stats

Current price $49.20
Prev. close $49.06
Day low $47.90
Day high $49.77
50-day MA $36.68
200-day MA $27.14
52-week high $51.84
52-week low $10.41
Volume 964,200
Avg. volume 1,670,904
Dividend yield N/A
Market Cap 4.66B

Arrowhead Pharmaceuticals, Inc. (ARWR) Company Bio


Arrowhead Pharmaceuticals is a biopharmaceutical company developing targeted RNAi therapeutics. The company was founded in 1989 and is based in Pasadena, California.





ARWR Latest News Stream


Event/Time News Detail
Loading, please wait...

ARWR Latest Social Stream


Loading social stream, please wait...

View Full ARWR Social Stream

ARWR Price Returns

1-mo 24.09%
3-mo 59.33%
6-mo 104.66%
1-year 279.92%
3-year 1,008.11%
5-year 733.90%
YTD 296.14%
2018 237.50%
2017 137.42%
2016 -74.80%
2015 -16.67%
2014 -31.98%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5734 seconds.